Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | MMM | CSX |
|---|---|---|
| Price | $169.17 | $46.83 |
| Change today | ▼ 0.66% | ▼ 0.77% |
| Market cap | $87.24B | $86.74B |
| Return, 3 months | +2.4% | +1.9% |
| Return, year to date | +7.2% | +30.4% |
| Return, 1 year | +11.4% | +40.2% |
| P/E (TTM) | 30.0 | 27.1 |
| P/B | 29.6 | 6.2 |
| P/E percentile vs own 5y | 90th | 91st |
| Dividend yield | 1.79% | 1.15% |
| Revenue growth (YoY, latest qtr) | +2.5% | +10.1% |
| Net profit growth (YoY) | +29.4% | +20.9% |
| Gross margin | 39.4% | 35.3% |
| Operating margin | 20.4% | 35.5% |
| Net margin | 11.9% | 22.2% |
| Return on equity | 82.8% | 24.4% |
| Analyst target vs. price | +9.2% | +15.2% |
| Analyst buy share | 45% | 74% |
| RSI (14) | 51 | 37 |
| 30-day volatility | 18.0% | 18.1% |
| Max drawdown, 1 year | -18.8% | -13.4% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.